{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "81af335d-4d82-4015-b65d-2e4af6f74b52", "code": "N03AG01", "comments": "ATC|NERVOUS SYSTEM|ANTIEPILEPTICS|ANTIEPILEPTICS|Fatty acid derivatives|valproic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=N03AG01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "d332de12-2951-413c-90f7-9e274c556825", "code": "N0000175751", "comments": "Established Pharmacologic Class [EPC]|Mood Stabilizer [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175751", "code_system": "NDF-RT", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "d5ef44ea-7fa9-4ed8-a3f2-e85fc5fecd09", "code": "N0000175753", "comments": "Established Pharmacologic Class [EPC]|Anti-epileptic Agent [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175753", "code_system": "NDF-RT", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "f8fd01f7-ba72-46b5-9cea-328d02844449", "code": "N0000008486", "comments": "Physiological Effects [PE]|Organ System Specific Effects [PE]|Nervous System Activity Alteration [PE]|Electrical Activity Alteration [PE]|Disorganized Electrical Activity Alteration [PE]|Decreased Disorganized Electrical Activity [PE]|Decreased Central Nervous System Disorganized Electrical Activity [PE]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000008486", "code_system": "NDF-RT", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "9f536103-df2a-4def-9f92-8ca55156c6b5", "code": "QN03AG01", "comments": "VATC|ANTIEPILEPTICS|ANTIEPILEPTICS|Fatty acid derivatives|valproic acid", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QN03AG01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "78621ab3-c293-4d0f-9820-a42ccc04f6fa", "code": "99-66-1", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=99-66-1", "code_system": "CAS", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723", "c851eef5-e7de-42b0-a6bb-0e926ea8da2e" ] }, { "uuid": "21ab50a9-8cf5-4537-97c7-865c64d109bd", "code": "C29536", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C29536", "code_system": "NCI_THESAURUS", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "25351e47-a853-429f-8369-1643e75814b7", "code": "NBK548284", "comments": "LiverTox|CNS|Anticonvulsant|Miscellaneous", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/NBK548284/", "code_system": "LIVERTOX", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "e226c6ea-2b52-4828-aa52-c4ea8765dc99", "code": "D014635", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68014635", "code_system": "MESH", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "efff83d3-aa8c-4bee-867d-de839aa591d7", "code": "VALPROIC ACID", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Valproic_acid", "code_system": "WIKIPEDIA", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "a1365fac-10b6-460c-9cba-25b88b820c1f", "code": "24.2.2", "comments": "WHO ESSENTIAL MEDICINES LIST|Medicines for mental and behavioural disorders|Medicines used in mood disorders|Medicines used in bipolar disorders", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/52/?section=152#type160", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "78ff306b-6855-4fbe-8e03-48d12426ecac", "code": "05", "comments": "WHO ESSENTIAL MEDICINES LIST|Anticonvulsants/antiepileptics", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/52/?section=42#type158", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "b6942ad9-0dda-45c6-aa19-887f5fc5f91c", "code": "3300", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=3300", "code_system": "INN", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "4bda0bf0-8094-44d5-a2ac-5d727535b21d", "code": "7009", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7009", "code_system": "IUPHAR", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "c151972b-e7f1-4245-a9e8-4816e8e3e0b8", "code": "m11369", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m11369?q=authorize", "code_system": "MERCK INDEX", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "5912d676-da82-4668-80cf-efae11e1e15b", "code": "40254", "type": "ALTERNATIVE", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/40254/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "46c12bec-cd3c-4db5-9f63-4cfecba4723a", "code": "11118", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/11118/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "d31ec24c-af0a-4f6e-ab1e-98d991d8fc2d", "code": "DB00313", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00313", "code_system": "DRUG BANK", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "39b238ff-a2f8-4be0-bb87-9bc8080af6fb", "code": "SUB00015MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "84c2c8bb-1e04-4f52-b4d6-e327e48321f0", "code": "CHEMBL109", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL109", "code_system": "ChEMBL", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "6cb4a456-7683-4cae-9034-b9ea0ea043a0", "code": "3121", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/3121", "code_system": "PUBCHEM", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "be793624-fc17-4e66-8f1d-9f4fed896fda", "code": "202-777-3", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.002.525", "code_system": "ECHA (EC/EINECS)", "references": [ "4d69f927-1420-46a0-a9c8-7ec30462f723" ] }, { "uuid": "13d590b3-9fa7-af01-7aee-411cd429fc04", "code": "3582", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/3582", "code_system": "HSDB", "references": [ "8b8c9d44-816c-a4fb-d869-f81054017422" ] }, { "uuid": "00d7a8ef-0acc-03c2-03c4-c28eb3832e79", "code": "DTXSID6023733", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID6023733", "code_system": "EPA CompTox", "references": [ "fd9596d3-7c6a-8002-0aae-abddd00b3fb5" ] }, { "uuid": "6a355f8f-71f3-fc1a-1d0f-706b08998865", "code": "256908", "comments": "ORPHAN DRUG|Designated|Treatment of fragile X syndrome", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=256908", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "3605b1cb-8c7d-5248-2acf-51cdc341f8c2", "code": "563116", "comments": "ORPHAN DRUG|Designated|Treatment of diffuse large B-cell lymphoma", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=563116", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "a30cd2ce-b911-9e4a-c471-7a76d1050e54", "code": "C264", "comments": "Pharmacologic Substance[C1909]|Agent Affecting Nervous System[C78272]|Anticonvulsant Agent", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C264", "code_system": "NCI_THESAURUS", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "b0388527-f50b-a433-a9ac-d5182e5ce415", "code": "EU/3/16/1792", "comments": "EU ORPHAN DRUG|Positive|Treatment of diffuse large B-cell lymphoma", "type": "PRIMARY", "url": "https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu3161792", "code_system": "EU-Orphan Drug", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "28de9d14-97aa-4d25-84c0-0b23a90b68b8", "code": "614OI1Z5WI", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "4c386ba2-d205-0be7-8944-e28038f15f35", "code": "Valproic Acid", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM403/", "code_system": "LACTMED", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "55d898cb-d954-3cab-559f-5dbab24dfde9", "code": "2803", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/2803", "code_system": "DRUG CENTRAL", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "cc8569cf-679e-b84a-5223-67638bf998b3", "code": "1708707", "type": "PRIMARY", "url": "https://store.usp.org/product/1708707", "code_system": "RS_ITEM_NUM", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "7d6e0d97-72cc-422f-1d5f-008f4b3c34c9", "code": "39867", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:39867", "code_system": "CHEBI", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "5266a810-5b8d-cbd5-2b07-798cc6d4ed7b", "code": "60654", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:60654", "code_system": "CHEBI", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "894f9d8f-1892-ecef-a29a-4030da3e90c5", "code": "9925", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:9925", "code_system": "CHEBI", "references": [ "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c" ] }, { "uuid": "3d443a0c-3bb5-91b1-80ac-da8fe385f982", "code": "614OI1Z5WI", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=614OI1Z5WI", "code_system": "DAILYMED", "references": [ "71278ce0-b657-be7c-ee7a-67e986156401" ] }, { "uuid": "069bb77d-33be-2f9d-e74f-9cb6c209a4e8", "code": "100000090423", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "dfddc849-586b-64c3-21f5-ab6c331ec9c2" ] } ], "substance_class": "chemical", "references": [ { "uuid": "03751845-78d3-03fb-4815-97e97f09507b", "citation": "European Pharmacopoeia Online 9.8, Valproic Acid Monograph", "doc_type": "EP", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "902f3bcd-5067-858b-a86e-65671bc2167f", "citation": "USP42-NF37 - 4532, Valproic Acid Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7f15821c-cd57-4645-8270-138f8feff4c5", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "5711a9f7-7f27-4f86-86e7-735da8b3adca", "citation": "USP DICTIONARY 2009", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "76b23f5f-c6fd-40e5-b064-d89360e4da5b", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "65b18d95-05db-436a-bf06-aa4f5633c35b", "citation": "INN Proposed List 28", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL28.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "e7818c73-927f-4a7d-a925-a148d4662712", "citation": "USP DICTIONARY 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "06ec99e4-c005-4d2c-9f82-0c4e3904e9ed", "citation": "EP 7.2", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "ae7b039f-3919-4944-82fd-4dd3d1c1ebb1", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "ac668a2d-92af-43dc-acdd-60bb4cf16785", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "b933bf92-c20a-4c3b-b448-e61cd2a3a792", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c5776dc5-28d3-4018-9c69-9ac0345c705b", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2c9fd511-09d7-4888-a6ce-fb438691678c", "citation": "rxnorm", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "6246236a-d96b-4d6b-9953-20299c0c7f86", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "893a2397-116f-41ca-8da2-7ee418b4110f", "citation": "USP/NF", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "bf1375cf-e56f-4067-8f75-769561b95580", "citation": "EMPIRICA", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "3ef6a40d-9dac-41cc-ae2e-a398fab40edf", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f52cec2a-34b2-4b4b-9347-4a00ab686c5b", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "15f4b54e-9baa-4190-87bd-0e411b00d3bb", "citation": "CHEMID", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "4d69f927-1420-46a0-a9c8-7ec30462f723", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389723000, "tags": [ "NOMEN" ] }, { "uuid": "f1df3f8f-0490-4539-b947-225cc4288ee3", "citation": "EP 7.8 VALPROIC ACID MONOGRAPH", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2e2220f1-c2c8-475b-b008-c32d2b949075", "citation": "USP 36 VALPROIC ACID MONOGRAPH", "doc_type": "USP", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d3d9635d-7354-4c1e-aa73-c78c610d0d11", "citation": "DRUG METABOLISM AND DISPOSITION 19.2 (1991): 525-535.", "url": "http://dmd.aspetjournals.org/content/19/2/525.full.pdf", "doc_type": "JOURNAL ARTICLE", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "42988420-07bd-48cf-8ff5-eeee658ea898", "citation": "SRS import [614OI1Z5WI]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=614OI1Z5WI", "doc_type": "SRS", "public_domain": true, "document_date": 1493389723000, "tags": [ "NOMEN" ] }, { "uuid": "0fcbcfb1-a767-4825-922d-7c45f40fff81", "citation": "VALPROIC ACID [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "65fea249-8cae-4f26-a1da-b7f7c0fa9c09", "citation": "VALPROIC ACID [USAN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "0aec45fe-baea-46a0-aea4-ec9f48d9cc5b", "citation": "VALPROIC ACID [EP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e0b8ae7f-e0bc-46fc-a682-dd852d3fe276", "citation": "VALPROIC ACID [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "8ecf842f-fec2-4daf-a7e9-72e91574f001", "citation": "VALPROIC ACID [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "9314eb8d-bc9b-4847-8f24-96873b74bd9f", "citation": "VALPROIC ACID [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "85a12989-d582-4371-b06a-3caa18ce3ff8", "citation": "VALPROIC ACID [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "41367c67-3b4c-4a1d-9569-0e762d2ea60b", "citation": "VALPROIC ACID [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "38ffd287-474e-41b9-855f-0d253c92851f", "citation": "VALPROIC ACID [USP-RS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "02e030a5-41dc-4a32-a790-9e365335e5bf", "citation": "VALPROIC ACID [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "e3715df7-8e0f-42af-9cca-39e8a80dc100", "citation": "VALPROIC ACID [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "faa32af1-4dff-6aab-c441-a907cfecee87", "citation": "Neurochemistry International\nVolume 37, Issues 2–3, 1 August 2000, Pages 103-110", "url": "http://www.sciencedirect.com/science/article/pii/S0197018600000139#bBIB46", "doc_type": "JA", "public_domain": true }, { "uuid": "2993dd2a-18ec-9d04-720c-678f588076c3", "citation": "Pharmacol Rev 65:578–640, April 2013", "url": "http://dx.doi.org/10.1124/pr.111.005439", "doc_type": "JA", "public_domain": true }, { "uuid": "8b8c9d44-816c-a4fb-d869-f81054017422", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+99-66-1", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b8dcd0f2-60f4-8186-db8a-f23c806e0835", "citation": "Kiang, Tony KL, et al. \"Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9* 1/* 1 genotype.\" Toxicological sciences 94.2 (2006): 261-271.", "url": "https://academic.oup.com/toxsci/article/94/2/261/1645563", "doc_type": "JA", "public_domain": true }, { "uuid": "14c13278-152d-8f26-8a52-4120ad8f70f5", "citation": "Abbott, Frank S., et al. \"The effect of aspirin on valproic acid metabolism.\" Clinical Pharmacology & Therapeutics 40.1 (1986): 94-100.", "url": "http://onlinelibrary.wiley.com/doi/10.1038/clpt.1986.144/full", "doc_type": "JA", "public_domain": true }, { "uuid": "fd9596d3-7c6a-8002-0aae-abddd00b3fb5", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=99-66-1", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "58d5a901-6606-3915-1752-975de4daf7b1", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+99-66-1", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "be462ef9-0462-a6bf-12fb-637698662aa2", "citation": "European Journal of Pharmaceutical Sciences, Volume 2, Issue 3, October 1994, Pages 239-244", "url": "https://www.sciencedirect.com/science/article/pii/0928098794900280", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "dfddc849-586b-64c3-21f5-ab6c331ec9c2", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "b11a1617-4e27-46e2-a680-8704b47afa63", "citation": "Sun, Lichun, et al. \"HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II.\" American Journal of Translational Research 10.2 (2018): 545.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835820/", "doc_type": "JA", "public_domain": true }, { "uuid": "5f6fba34-cfaf-39a9-fd3d-40a30d80ae5c", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "0ed8e014-9650-e5c1-f340-a71bd1db90d1", "citation": "Pharmacogenet Genomics. 2013 Apr; 23(4): 236–241.", "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696515/", "doc_type": "JA", "public_domain": true }, { "uuid": "c851eef5-e7de-42b0-a6bb-0e926ea8da2e", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "2d964f3a-6a29-30c2-988e-2c78cd433f81", "citation": "PCPC", "doc_type": "PERSONAL CARE PRODUCTS COUNCIL", "public_domain": true }, { "uuid": "e4ad8893-bfbc-4f23-a119-08c8a9c53cb0", "citation": "Singh, Dhirendra, et al. \"Hidden pharmacological activities of valproic acid: A new insight.\" Biomedicine & Pharmacotherapy 142 (2021): 112021.", "url": "https://www.sciencedirect.com/science/article/pii/S0753332221008040", "doc_type": "JA", "public_domain": true }, { "uuid": "8712a446-3a33-40d3-822d-99a48e56a70d", "citation": "Kurz, Michael, and Gerhard KE Scriba. \"Drug–phospholipid conjugates as potential prodrugs: synthesis, characterization, and degradation by pancreatic phospholipase A2.\" Chemistry and physics of lipids 107.2 (2000): 143-157.", "url": ".https://www.sciencedirect.com/science/article/abs/pii/S0009308400001675", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "7c001722-71d8-460e-a5c3-22548093516c", "citation": "Kurz, Michael, and Gerhard KE Scriba. \"Drug–phospholipid conjugates as potential prodrugs: synthesis, characterization, and degradation by pancreatic phospholipase A2.\" Chemistry and physics of lipids 107.2 (2000): 143-157.", "url": ".https://www.sciencedirect.com/science/article/abs/pii/S0009308400001675", "doc_type": "JA", "public_domain": true }, { "uuid": "5af9307a-6fd4-4d70-82e3-5bc3f4713f5f", "citation": "Drug Metab Dispos 1985;13(1):81", "doc_type": "JA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b70fed07-6d05-6e46-7eaa-2092ce61b4a1", "citation": "USP 10/2020", "doc_type": "USPNF", "public_domain": true }, { "uuid": "d18b71a4-6f73-78fc-8a69-cc7939c289e2", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "5174d165-3bc7-e2de-2cf6-51ba7e4c6685", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "71278ce0-b657-be7c-ee7a-67e986156401", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "a7a470d7-aecc-4aa7-85b8-a1612259eda0", "citation": "https://en.wikipedia.org/wiki/Valproate_pivoxil", "url": "https://en.wikipedia.org/wiki/Valproate_pivoxil", "doc_type": "WIKI", "public_domain": true } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "8910335b-4d74-460b-86d9-d1ec3ec25b1d", "id": "8910335b-4d74-460b-86d9-d1ec3ec25b1d", "molfile": "\n Marvin 01132107072D \n\n 10 9 0 0 0 0 999 V2000\n 2.8905 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4813 -0.7252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6499 -0.7252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.2381 -1.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6499 -2.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4813 -2.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8905 -2.8621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.4144 -1.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -0.7252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -2.1472 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 0 0 0 0\n 2 3 1 0 0 0 0\n 3 4 1 0 0 0 0\n 5 4 1 0 0 0 0\n 4 8 1 0 0 0 0\n 6 5 1 0 0 0 0\n 7 6 1 0 0 0 0\n 9 8 1 0 0 0 0\n 10 8 2 0 0 0 0\nM END", "smiles": "CCCC(CCC)C(=O)O", "formula": "C8H16O2", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "da073b68-cd39-487e-a524-41327d895054" }, "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "144.2117", "optical_activity": "NONE", "stereo_centers": 0 } ], "definition_level": "COMPLETE", "uuid": "5ca02822-9993-4a2b-965a-58bd8dfca7c2", "version": "76", "structure": { "id": "2312d076-36b8-45e1-940a-01b50f4bffb6", "molfile": "\n Marvin 01132101582D \n\n 10 9 0 0 0 0 999 V2000\n 0.4144 -1.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -0.7252 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1.2381 -1.4401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 0.0000 -2.1472 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6499 -0.7252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1.6499 -2.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4813 -0.7252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.4813 -2.1472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8905 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2.8905 -2.8621 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 2 0 0 0 0\n 3 1 1 0 0 0 0\n 4 1 1 0 0 0 0\n 5 3 1 0 0 0 0\n 6 3 1 0 0 0 0\n 7 5 1 0 0 0 0\n 8 6 1 0 0 0 0\n 9 7 1 0 0 0 0\n 10 8 1 0 0 0 0\nM END", "smiles": "CCCC(CCC)C(=O)O", "formula": "C8H16O2", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ACHIRAL", "defined_stereo": 0, "ez_centers": 0, "molecular_weight": "144.2117", "optical_activity": "NONE", "references": [ "7f15821c-cd57-4645-8270-138f8feff4c5", "42988420-07bd-48cf-8ff5-eeee658ea898", "65b18d95-05db-436a-bf06-aa4f5633c35b" ], "stereo_centers": 0 }, "unii": "614OI1Z5WI", "relationships": [ { "uuid": "cef493df-f987-4e59-b733-13ff63d46144", "amount": { "uuid": "c4f4c7eb-c26c-4674-a843-45ec63ce8372" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "61553d14-51f4-4223-9e52-6d3c4e5d7dc1", "refuuid": "5ca02822-9993-4a2b-965a-58bd8dfca7c2", "name": "VALPROIC ACID", "unii": "614OI1Z5WI", "linking_id": "614OI1Z5WI", "ref_pname": "VALPROIC ACID", "substance_class": "reference" } }, { "uuid": "a5b8356c-9eef-48b1-b9aa-db382738a696", "amount": { "uuid": "5ca0cd25-d7f8-4291-8cd4-bba80c46a80b" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "fdde5bed-03b2-4660-8400-041f38199cbd", "refuuid": "0b23910b-e1a0-4d87-b4fc-208f6a24a995", "name": "VALPROATE BISMUTH", "unii": "87PTX621FI", "linking_id": "87PTX621FI", "ref_pname": "VALPROATE BISMUTH", "substance_class": "reference" } }, { "uuid": "296659ca-fb82-48b9-99c3-ecaded2c8109", "amount": { "uuid": "b645d150-38df-4fd6-b887-c6f4bec85526" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "667229c1-dc06-48f8-8bb6-e5d9d7659c79", "refuuid": "5bf8f8b2-1f72-463a-80d1-84c3fc42aa54", "name": "VALPROATE CALCIUM", "unii": "56CCK4F86G", "linking_id": "56CCK4F86G", "ref_pname": "VALPROATE CALCIUM", "substance_class": "reference" } }, { "uuid": "350e4aa1-2b77-4508-a587-689840ff8cd6", "amount": { "uuid": "2a3281f6-fe6d-48c7-b639-802fdcd94d10" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "92eb9e28-28cd-4be9-9985-4e7c921fda3b", "refuuid": "375b7b7a-3934-4e76-bbe4-1e459f802a28", "name": "VALPROATE MAGNESIUM", "unii": "Q400352CM2", "linking_id": "Q400352CM2", "ref_pname": "VALPROATE MAGNESIUM", "substance_class": "reference" } }, { "uuid": "bb5e495e-002a-49de-a3a0-dc00d10a76f3", "amount": { "uuid": "c2576365-c100-482b-b055-b66b558cfbb6" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "770ae4ce-d938-43b6-a8b5-704d98c3fe49", "refuuid": "65135413-2cd3-4e8c-8cb0-0567d479255e", "name": "VALPROATE SODIUM", "unii": "5VOM6GYJ0D", "linking_id": "5VOM6GYJ0D", "ref_pname": "VALPROATE SODIUM", "substance_class": "reference" } }, { "uuid": "525f419e-734a-4334-9b62-700cdad1c531", "amount": { "uuid": "08148c32-9ae6-40a5-8516-e0be1747027b" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "244cce1f-cbbf-4813-9904-6d19731365af", "refuuid": "624d4cfb-9858-4086-af85-4eb985041f50", "name": "DIVALPROEX SODIUM", "unii": "644VL95AO6", "linking_id": "644VL95AO6", "ref_pname": "DIVALPROEX SODIUM", "substance_class": "reference" } }, { "uuid": "fa9f81d7-c8f0-4ced-b6ce-f6c34c5bf5d6", "amount": { "uuid": "21aeaf31-08b4-47a8-8294-3b78ba084ddf", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 101, "low_limit": 99 }, "qualification": "EP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "ASSAY (TITRATION)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3" ], "related_substance": { "uuid": "0fe81836-56fd-42b9-8136-acb83ac1b233", "refuuid": "5ca02822-9993-4a2b-965a-58bd8dfca7c2", "name": "VALPROIC ACID", "unii": "614OI1Z5WI", "linking_id": "614OI1Z5WI", "ref_pname": "VALPROIC ACID", "substance_class": "reference" } }, { "uuid": "cdaaa42f-86c3-4a96-a07b-45f5668c5b9a", "amount": { "uuid": "ae5996e9-8b55-4174-a55e-f5d1b4cf9189", "type": "RELATIONSHIP_AMOUNT", "units": "WEIGHT PERCENT", "high_limit": 102, "low_limit": 98 }, "qualification": "USP", "type": "BASIS OF STRENGTH->SUBSTANCE", "interaction_type": "ASSAY (HPLC)", "references": [ "2e2220f1-c2c8-475b-b008-c32d2b949075" ], "related_substance": { "uuid": "ed5b6963-2bff-42e5-a8e6-f5345d0409d4", "refuuid": "5ca02822-9993-4a2b-965a-58bd8dfca7c2", "name": "VALPROIC ACID", "unii": "614OI1Z5WI", "linking_id": "614OI1Z5WI", "ref_pname": "VALPROIC ACID", "substance_class": "reference" } }, { "uuid": "7e6b9a0a-dd75-4ba9-9df5-83a098e29888", "amount": { "uuid": "102d5132-0065-47ab-8c2c-4a5713c0a3fd", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "639dd7d9-60ad-4705-be73-77e28884dbc7", "refuuid": "8eb8c241-0fe9-4f9d-a01d-54fd19befe02", "name": "Valeric acid", "unii": "GZK92PJM7B", "linking_id": "GZK92PJM7B", "ref_pname": "Valeric acid", "substance_class": "reference" } }, { "uuid": "14491ddd-5fb1-4239-85ca-5eb1d2dae9a0", "amount": { "uuid": "54d31350-b083-495d-a9c0-56bc8498a799", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "fe4f64b0-c61b-4310-98e5-92a41ffd8d0a", "refuuid": "f7b9186b-ada6-42dc-84b6-a4fa25056c73", "name": "2-ETHYLPENTANOIC ACID", "unii": "JC688J0RH8", "linking_id": "JC688J0RH8", "ref_pname": "2-ETHYLPENTANOIC ACID", "substance_class": "reference" } }, { "uuid": "e921f5e7-5db0-4b56-b0a4-90f7859893eb", "amount": { "uuid": "10ead1d6-086f-4895-ac09-0f934b1d9183", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "558b4fad-cf89-4700-bd6a-79ebb9f580aa", "refuuid": "69b05019-3c20-447f-a823-fe4783abbe72", "name": "2-ISOPROPYLPENTANOIC ACID", "unii": "2B1J2157CO", "linking_id": "2B1J2157CO", "ref_pname": "2-ISOPROPYLPENTANOIC ACID", "substance_class": "reference" } }, { "uuid": "8b030a45-db34-4ef7-800c-4dc0f5d3277b", "amount": { "uuid": "17237487-8c9b-47e4-9681-3cf6541d6a24", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "2ace0093-fc77-437b-aa4a-13b86517f3e2", "refuuid": "bc65b31f-a3e3-416f-bee2-d760252afa9a", "name": "2,2-DIPROPYLPENTANOIC ACID", "unii": "J6TN518LGK", "linking_id": "J6TN518LGK", "ref_pname": "2,2-DIPROPYLPENTANOIC ACID", "substance_class": "reference" } }, { "uuid": "2cdea43a-38e6-4b83-aa79-b80679109632", "amount": { "uuid": "0029e978-7fed-4b57-a675-4cd40ccff0de", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "f6940626-cb06-4446-970a-52ce684ab36a", "refuuid": "400374d4-1c62-49a8-a027-7eb92a5d5c3d", "name": "VALERAMIDE", "unii": "TKL9TN43QK", "linking_id": "TKL9TN43QK", "ref_pname": "VALERAMIDE", "substance_class": "reference" } }, { "uuid": "474cdea5-57f1-46dd-9435-c71e17304462", "amount": { "uuid": "9f86cb6b-d73a-4549-91a1-4a0f608de361", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "38b46c66-0621-4688-acb6-993f497679f1", "refuuid": "f1bec2f1-cf8f-4dbf-ac08-5176940b10b7", "name": "VALPROMIDE", "unii": "RUA6CWU76G", "linking_id": "RUA6CWU76G", "ref_pname": "VALPROMIDE", "substance_class": "reference" } }, { "uuid": "1bc98699-810e-4ad3-a20f-1b1cd3f1a148", "amount": { "uuid": "991b6ae8-bc90-44b1-80cf-4662a6be2a89", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "62915491-8254-4f3c-a5af-d2c1edfb246a", "refuuid": "b97c3bb3-73cf-4e65-a2b6-59e3a7da5b77", "name": "VALDIPROMIDE", "unii": "8JAK753213", "linking_id": "8JAK753213", "ref_pname": "VALDIPROMIDE", "substance_class": "reference" } }, { "uuid": "3f0406cf-07a0-4cf2-9ae1-b1eea500d6dd", "amount": { "uuid": "9a48826a-a326-4856-9f17-b557e6d64301", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "2450bd53-9b11-441f-8de4-9ecb1efc3234", "refuuid": "cd8f07cb-72eb-47ab-8f0c-3c893258d2e2", "name": "VALERONITRILE", "unii": "X44H3R47D4", "linking_id": "X44H3R47D4", "ref_pname": "VALERONITRILE", "substance_class": "reference" } }, { "uuid": "2ce10c2b-d557-4339-82d5-a77378f98ffd", "amount": { "uuid": "47ac41dc-705d-4adb-b13f-7ee13c4889c3", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "4c931b29-091b-447d-a1b4-9c0d3492c230", "refuuid": "6214f2ae-833a-485a-bbfe-fca15b8e7e68", "name": "2-PROPYLVALERONITRILE", "unii": "HTD29QGA4I", "linking_id": "HTD29QGA4I", "ref_pname": "2-PROPYLVALERONITRILE", "substance_class": "reference" } }, { "uuid": "7691f003-7a62-4df2-b97e-b966a2825260", "amount": { "uuid": "9b71e5b7-9f08-40d2-9ecc-1615d6734bc5", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "51bcbbc3-4471-403a-aa35-ba22400282da", "refuuid": "caf08085-dd8f-4806-8150-08616f10f67c", "name": "2,2-DIPROPYLVALERONITRILE", "unii": "GE87M2OA61", "linking_id": "GE87M2OA61", "ref_pname": "2,2-DIPROPYLVALERONITRILE", "substance_class": "reference" } }, { "uuid": "f322fd1f-6ed3-4b80-b1c6-34ddba9a0b19", "amount": { "uuid": "51466dd5-b3eb-4650-bafa-b5a7fa78d793", "units": "PERCENT PEAK AREA", "high_limit": 0.05 }, "comments": "UNSPECIFIED", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "48d635ad-a639-454d-a7d5-c7ddfb90d277", "refuuid": "7733c17c-c9f8-476d-b618-25cbeb057843", "name": "2-METHYLPENTANOIC ACID", "unii": "26A19CG6J9", "linking_id": "26A19CG6J9", "ref_pname": "2-METHYLPENTANOIC ACID", "substance_class": "reference" } }, { "uuid": "582889de-69b6-4c90-904e-75926e9e211e", "amount": { "uuid": "67fe0da3-8e25-4109-91c7-8114660337db", "units": "PERCENT PEAK AREA", "high_limit": 0.15 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (GC)", "references": [ "f1df3f8f-0490-4539-b947-225cc4288ee3", "03751845-78d3-03fb-4815-97e97f09507b" ], "related_substance": { "uuid": "b0a45b0a-c7e5-49e0-bb63-f837690e973e", "refuuid": "6c92f8dc-fa39-4e53-ac61-5a22a10086f0", "name": "2-ETHYL-2-METHYLPENTANOIC ACID", "unii": "IFK7LO5002", "linking_id": "IFK7LO5002", "ref_pname": "2-ETHYL-2-METHYLPENTANOIC ACID", "substance_class": "reference" } }, { "uuid": "3e55f1ae-0809-4a7a-bac8-6f21ee9d2666", "amount": { "uuid": "5dc1a05f-869c-4bcd-9e84-fbca3842d572" }, "qualification": "URINE", "type": "METABOLITE TOXIC->PARENT", "interaction_type": "MINOR", "mediator_substance": { "uuid": "6e51990a-3cc2-4be2-92cb-c8871b2c7e9d", "refuuid": "50fbc0e6-a35d-4d72-849b-84bfc9d44cd5", "name": "CYTOCHROME P450 2C9", "unii": "L9DP834D1P", "linking_id": "L9DP834D1P", "ref_pname": "CYTOCHROME P450 2C9", "substance_class": "reference" }, "references": [ "5af9307a-6fd4-4d70-82e3-5bc3f4713f5f" ], "related_substance": { "uuid": "4771dd0d-73b4-4825-841d-69e2208c2bf4", "refuuid": "0faf1c67-6c28-4ac8-b874-fc48a4d090d9", "name": "2-PROPYL-4-PENTENOIC ACID", "unii": "2GYI36I25W", "linking_id": "2GYI36I25W", "ref_pname": "2-PROPYL-4-PENTENOIC ACID", "substance_class": "reference" } }, { "uuid": "02334680-e28b-4a36-ae26-41124e767357", "amount": { "uuid": "714d324e-69ef-419a-8e12-e211b986969b", "high": 1000, "low": 500, "units": "MICROMOLAR" }, "comments": "In vitro studies have shown that VPA is a potent inhibitor of SSA-DH. In brain homogenates, GABA-T is inhibited at high concentrations only. VPA increases GABA levels probably by increasing succinic semialdehyde, a good endogenous inhibitor of GABA-T. Evidence has emerged that valproate exerts a direct effect on excitable membranes and also attenuates the NMDA receptor channel.", "qualification": "IC50", "type": "TARGET->INHIBITOR", "interaction_type": "COMPETITIVE INHIBITOR", "references": [ "faa32af1-4dff-6aab-c441-a907cfecee87" ], "related_substance": { "uuid": "d5fb6fcd-83c9-4612-adf4-70a6f16302ed", "refuuid": "3998c2a0-ff11-428c-baaf-8b7bb9120d83", "name": "SUCCINATE-SEMIALDEHYDE DEHYDROGENASE, MITOCHONDRIAL", "unii": "0U442U21HI", "linking_id": "0U442U21HI", "ref_pname": "SUCCINATE-SEMIALDEHYDE DEHYDROGENASE, MITOCHONDRIAL", "substance_class": "reference" } }, { "uuid": "9ee27388-7326-406e-85ff-322689ec9ed1", "amount": { "uuid": "9e399b80-5e89-4858-b5a9-69e5b4f4078a" }, "type": "METABOLIC ENZYME->SUBSTRATE", "interaction_type": "MINOR", "references": [ "b8dcd0f2-60f4-8186-db8a-f23c806e0835" ], "related_substance": { "uuid": "8b78eada-4181-44ec-bc6e-2077e0e136cc", "refuuid": "660246ec-9ab8-48a7-935b-3c32fc934075", "name": "CYTOCHROME P450 2A6", "unii": "246D9TQ2XG", "linking_id": "246D9TQ2XG", "ref_pname": "CYTOCHROME P450 2A6", "substance_class": "reference" } }, { "uuid": "12d87e08-4320-4cad-b7eb-8d7a3a178dbc", "amount": { "uuid": "888b94fd-5e58-4d1d-9e96-4f7b81844efd" }, "type": "METABOLIC ENZYME->SUBSTRATE", "interaction_type": "MAJOR", "references": [ "b8dcd0f2-60f4-8186-db8a-f23c806e0835" ], "related_substance": { "uuid": "2e832e84-b5d6-4c6b-88cd-f8ced5387c22", "refuuid": "50fbc0e6-a35d-4d72-849b-84bfc9d44cd5", "name": "CYTOCHROME P450 2C9", "unii": "L9DP834D1P", "linking_id": "L9DP834D1P", "ref_pname": "CYTOCHROME P450 2C9", "substance_class": "reference" } }, { "uuid": "38d0bc3f-9fb8-414c-ad8a-eff731cfcad1", "amount": { "uuid": "60406467-9b08-474c-a3b1-0558c641e26b" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "b8dcd0f2-60f4-8186-db8a-f23c806e0835" ], "related_substance": { "uuid": "1718b451-07bd-41d1-847f-497c7c25ebd9", "refuuid": "83e3f07e-be5b-48ac-be08-0c68c20e8bf0", "name": "CYTOCHROME P450 2B6", "unii": "0UY97CSG1T", "linking_id": "0UY97CSG1T", "ref_pname": "CYTOCHROME P450 2B6", "substance_class": "reference" } }, { "uuid": "468f0f33-0769-48c5-9d1a-ebb7c3df9cdc", "amount": { "uuid": "b437f0da-d15b-4588-b68b-66abc486f7dd" }, "type": "METABOLITE->PARENT", "related_substance": { "uuid": "1f3f4c10-4210-465a-b457-979c6948ac44", "refuuid": "c1890251-7136-4bc2-9a13-351d992946be", "name": "2-PROPYL-2-PENTENOIC ACID, (2E)-", "unii": "6W67L10M6T", "linking_id": "6W67L10M6T", "ref_pname": "2-PROPYL-2-PENTENOIC ACID, (2E)-" } }, { "uuid": "dfd42fcf-003e-4a38-82f4-69ba0155b4b1", "amount": { "uuid": "bf4d567f-0d10-4707-9a63-2ce4ce81c027", "type": "MOLE PERCENT OF AMOUNT EXCRETED", "average": 20.2, "high": 27.9, "low": 10.5, "units": "%" }, "comments": "REDUCED IN THE PRESENCE OF ASA", "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "14c13278-152d-8f26-8a52-4120ad8f70f5" ], "related_substance": { "uuid": "9f15d9d4-ab1f-4f32-a1bc-8b8d74eda2f7", "refuuid": "d13a37fd-ea99-4e9e-9ccf-57f0178889e1", "name": "3-KETOVALPROIC ACID", "unii": "HIZ0PV4PQ1", "linking_id": "HIZ0PV4PQ1", "ref_pname": "3-KETOVALPROIC ACID", "substance_class": "reference" } }, { "uuid": "618edf25-825e-4d20-99e4-8308da689580", "amount": { "uuid": "614c79ec-0b30-4dec-9306-6fd464131b26", "average": 90, "units": "%" }, "type": "BINDER->LIGAND", "references": [ "2993dd2a-18ec-9d04-720c-678f588076c3" ], "related_substance": { "uuid": "8613adcb-7f29-4407-bf46-c4fa00e9ba24", "refuuid": "e95d330b-4c2d-44bb-a61b-860afeb4aa30", "name": "PLASMA PROTEIN FRACTION (HUMAN)", "unii": "6D53G0FD0Z", "linking_id": "6D53G0FD0Z", "ref_pname": "PLASMA PROTEIN FRACTION (HUMAN)", "substance_class": "reference" } }, { "uuid": "697bde16-d5ec-4c0b-8022-d085f7f109bb", "amount": { "uuid": "d27a61de-b47d-4d9e-aa1b-5afce78ec8f2", "type": "MOLE PERCENT OF AMOUNT EXCRETED", "average": 2.65, "high": 4.95, "low": 0.35, "units": "%" }, "comments": "contributes partially", "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MINOR", "mediator_substance": { "uuid": "e801f41a-8141-4fca-b2e5-cd39f3da1d95", "refuuid": "660246ec-9ab8-48a7-935b-3c32fc934075", "name": "CYTOCHROME P450 2A6", "unii": "246D9TQ2XG", "linking_id": "246D9TQ2XG", "ref_pname": "CYTOCHROME P450 2A6", "substance_class": "reference" }, "references": [ "0ed8e014-9650-e5c1-f340-a71bd1db90d1", "b8dcd0f2-60f4-8186-db8a-f23c806e0835" ], "related_substance": { "uuid": "fabad648-bdc3-407e-baf0-03c91541c7a5", "refuuid": "1e9f0116-52e4-4094-adbf-94dfddd62fc3", "name": "3-HYDROXY-VALPROIC ACID", "unii": "CW51396YVP", "linking_id": "CW51396YVP", "ref_pname": "3-HYDROXY-VALPROIC ACID", "substance_class": "reference" } }, { "uuid": "f7627bcf-df87-455c-8d26-426884ed8edc", "amount": { "uuid": "2006e6d4-80ad-425a-9b3a-30662bdfd776" }, "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "be462ef9-0462-a6bf-12fb-637698662aa2" ], "related_substance": { "uuid": "6d747ebf-7e1a-4f0c-8a20-50530e2c2a54", "refuuid": "9e6c81fe-4a6a-4972-839e-2d0c9456ba01", "name": "1-(ETHOXYCARBONYLOXY)ETHYL VALPROATE", "unii": "D9VW6400WJ", "linking_id": "D9VW6400WJ", "ref_pname": "1-(ETHOXYCARBONYLOXY)ETHYL VALPROATE", "substance_class": "reference" } }, { "uuid": "05df3850-46a6-4b2f-b5f2-10c6b61ef05b", "amount": { "uuid": "26afa911-3fb5-48f8-b18c-71c9bab7e8e8", "type": "MOLE PERCENT OF AMOUNT EXCRETED", "average": 50.5, "high": 63.1, "low": 37.9, "units": "%" }, "qualification": "URINE", "type": "METABOLITE->PARENT", "interaction_type": "MAJOR", "references": [ "14c13278-152d-8f26-8a52-4120ad8f70f5" ], "related_substance": { "uuid": "9670de79-6ba7-46f4-9b75-d6b8d08b869e", "refuuid": "b34fcebc-36ef-4d9e-b574-c0fa074acc7b", "name": "VALPROATE GLUCURONIDE", "unii": "SB05J7266C", "linking_id": "SB05J7266C", "ref_pname": "VALPROATE GLUCURONIDE", "substance_class": "reference" } }, { "uuid": "a6d90b4c-09de-44eb-aa67-b2bebc3192f3", "amount": { "uuid": "25325e30-e87a-4dad-835f-73dc714e361f" }, "type": "TARGET->INHIBITOR OF EXPRESSION", "references": [ "b11a1617-4e27-46e2-a680-8704b47afa63" ], "related_substance": { "uuid": "c29617fa-9104-4638-9679-b6d8984dd300", "refuuid": "f4059ede-e9b2-4a24-964b-dce469917009", "name": "HISTONE DEACETYLASE 4", "unii": "KJ1F8SDB3A", "linking_id": "KJ1F8SDB3A", "ref_pname": "HISTONE DEACETYLASE 4", "substance_class": "reference" } }, { "uuid": "d9e4ddf6-0a46-4776-82c0-a8b246971d2f", "amount": { "uuid": "2fbc520a-1332-4e6e-b523-ce036c1649a2" }, "comments": "Depletes levels of L-carnitine", "type": "METABOLITE->PARENT", "related_substance": { "uuid": "b5ce7e80-f281-40a2-b38a-9098f73f2a85", "refuuid": "23a5b5f9-9aaa-4f4b-b0e5-e39b74d92e68", "name": "Valproylcarnitine", "unii": "5Q9MQB3YZR", "linking_id": "5Q9MQB3YZR", "ref_pname": "Valproylcarnitine", "substance_class": "reference" } }, { "uuid": "7c8a4096-c521-4819-b34e-23351653204d", "amount": { "uuid": "ed53b069-2c38-4972-a4cc-5e2a84964d70" }, "type": "PRODRUG->METABOLITE ACTIVE", "mediator_substance": { "uuid": "bcffe601-8e48-4f1a-86a5-a03b8655ccca", "refuuid": "2316be0d-e567-4d8e-9c6f-fc0c2168119d", "name": "PHOSPHOLIPASE A2 GROUP 1B", "unii": "4G82SY7QP6", "linking_id": "4G82SY7QP6", "ref_pname": "PHOSPHOLIPASE A2 GROUP 1B", "substance_class": "reference" }, "references": [ "7c001722-71d8-460e-a5c3-22548093516c" ], "related_substance": { "uuid": "c8a1394a-5af4-4e65-bfa3-9546a9ffbf1c", "refuuid": "efeed112-5d63-4708-ae0e-c65ee31c7ab4", "name": "1-PALMITOYL-2-VALPROYL-SN-GLYCERO-3-PHOSPHOCHOLINE", "unii": "3FGD5KPJ8G", "linking_id": "3FGD5KPJ8G", "ref_pname": "1-PALMITOYL-2-VALPROYL-SN-GLYCERO-3-PHOSPHOCHOLINE", "substance_class": "reference" } }, { "uuid": "7e506bba-a731-4665-bd97-2c5360a84c66", "amount": { "uuid": "d6e99b33-e81e-4925-a5cb-3035ae2128d1" }, "type": "PRODRUG->METABOLITE ACTIVE", "mediator_substance": { "uuid": "e4373d88-9d62-4ed0-879d-2707ff7a05bc", "refuuid": "2316be0d-e567-4d8e-9c6f-fc0c2168119d", "name": "PHOSPHOLIPASE A2 GROUP 1B", "unii": "4G82SY7QP6", "linking_id": "4G82SY7QP6", "ref_pname": "PHOSPHOLIPASE A2 GROUP 1B", "substance_class": "reference" }, "references": [ "8712a446-3a33-40d3-822d-99a48e56a70d" ], "related_substance": { "uuid": "fc6aa1cf-c557-402e-b7b1-65d49c2181d1", "refuuid": "5e41b82a-a80e-49f7-9cda-a92429899141", "name": "1-STEAROYL-2-VALPROYL-SN-GLYCERO-3-PHOSPHOCHOLINE", "unii": "W8XK4FDP8E", "linking_id": "W8XK4FDP8E", "ref_pname": "1-STEAROYL-2-VALPROYL-SN-GLYCERO-3-PHOSPHOCHOLINE", "substance_class": "reference" } }, { "uuid": "68557774-716f-41c8-8dcd-8d8329e5d383", "amount": { "uuid": "aa4c8e3e-b111-48e9-9eac-0e7319607542" }, "type": "TARGET->INHIBITOR", "references": [ "e4ad8893-bfbc-4f23-a119-08c8a9c53cb0" ], "related_substance": { "uuid": "6c530b23-bd2d-4a3d-a735-677ac3ef5181", "refuuid": "f4059ede-e9b2-4a24-964b-dce469917009", "name": "HISTONE DEACETYLASE 4", "unii": "KJ1F8SDB3A", "linking_id": "KJ1F8SDB3A", "ref_pname": "HISTONE DEACETYLASE 4", "substance_class": "reference" } }, { "uuid": "6bbd46b2-fbd4-4d86-8f3d-282f6a998042", "amount": { "uuid": "030d87c2-a6b6-4e42-b8bf-e5869c2fc244" }, "type": "TARGET->INHIBITOR", "references": [ "e4ad8893-bfbc-4f23-a119-08c8a9c53cb0" ], "related_substance": { "uuid": "91e70e5b-bbd3-4fb6-917e-9b0a114ce35f", "refuuid": "132d680a-0601-4936-8f34-0de10f38c775", "name": "HISTONE DEACETYLASE 3", "unii": "7YNS2RVD5Q", "linking_id": "7YNS2RVD5Q", "ref_pname": "HISTONE DEACETYLASE 3", "substance_class": "reference" } }, { "uuid": "19fd30f2-53f8-46bd-bd8d-053ebd8e8714", "amount": { "uuid": "54dfb87c-1690-4112-9cb2-8c30786b49a7" }, "type": "TARGET->INHIBITOR", "references": [ "e4ad8893-bfbc-4f23-a119-08c8a9c53cb0" ], "related_substance": { "uuid": "28ef73d4-4c6c-4299-82b7-f737a916a8bf", "refuuid": "b64910e4-8a58-43c6-84f9-4f9aff04f9aa", "name": "HISTONE DEACETYLASE 2", "unii": "RV2QAE6UDF", "linking_id": "RV2QAE6UDF", "ref_pname": "HISTONE DEACETYLASE 2", "substance_class": "reference" } }, { "uuid": "dd4f5b98-39d0-44ca-af7d-c488bdd24bfa", "amount": { "uuid": "8a3d3bdc-79e9-4c87-b194-3f7a0303ee95" }, "type": "TARGET->INHIBITOR", "references": [ "e4ad8893-bfbc-4f23-a119-08c8a9c53cb0" ], "related_substance": { "uuid": "38e9bc96-5e7c-4296-8296-3c5417e8c469", "refuuid": "c58e1c58-9cef-47a0-a99b-98343ca55c0c", "name": "HISTONE DEACETYLASE 1", "unii": "O037NFL7YQ", "linking_id": "O037NFL7YQ", "ref_pname": "HISTONE DEACETYLASE 1", "substance_class": "reference" } }, { "uuid": "6a884a0a-28f4-4bac-8524-e8a268de4760", "amount": { "uuid": "871cce52-2c45-4406-b50c-8a35c55b34fb" }, "type": "TARGET->INHIBITOR", "references": [ "e4ad8893-bfbc-4f23-a119-08c8a9c53cb0" ], "related_substance": { "uuid": "22b8d5fc-be16-4624-9238-fb5cb2d163db", "refuuid": "3b6a08de-54ce-4309-a114-0f4346a23acb", "name": "HISTONE DEACETYLASE 8", "unii": "IBD7PU4RLC", "linking_id": "IBD7PU4RLC", "ref_pname": "HISTONE DEACETYLASE 8", "substance_class": "reference" } }, { "uuid": "353a49f4-67e6-4c7d-aa06-39b78550ef80", "amount": { "uuid": "2cf74365-8ba3-468a-b8c8-0a290d8c4261" }, "type": "TARGET->INHIBITOR", "references": [ "e4ad8893-bfbc-4f23-a119-08c8a9c53cb0" ], "related_substance": { "uuid": "3b4ef768-4137-41a8-8665-51a5f6f5bc03", "refuuid": "bee6e532-ed0d-4c19-830b-92e5c623c7c0", "name": "HISTONE DEACETYLASE 6", "unii": "X6HV7Q6XP4", "linking_id": "X6HV7Q6XP4", "ref_pname": "HISTONE DEACETYLASE 6", "substance_class": "reference" } }, { "uuid": "e6d7e20a-0772-412d-8b4c-517e871a5f70", "amount": { "uuid": "58072230-6324-4d3e-be62-ed78b7d123a6" }, "type": "TARGET->INHIBITOR", "references": [ "e4ad8893-bfbc-4f23-a119-08c8a9c53cb0" ], "related_substance": { "uuid": "86e0defe-abc9-44ce-af9f-16c75db2735d", "refuuid": "e220ef91-2e89-4b26-aa34-31362111d8f7", "name": "4-AMINOBUTYRATE AMINOTRANSFERASE, MITOCHONDRIAL", "unii": "Z17FQI83OT", "linking_id": "Z17FQI83OT", "ref_pname": "4-AMINOBUTYRATE AMINOTRANSFERASE, MITOCHONDRIAL", "substance_class": "reference" } }, { "uuid": "8945941c-3d84-421a-a32f-fe2a256351ed", "amount": { "uuid": "620886b7-aa53-4842-97d3-cdb072f5203b" }, "type": "PARENT->METABOLITE ACTIVE", "related_substance": { "uuid": "a5324ae5-c26d-4735-b212-82c8ac9b9780", "refuuid": "f1bec2f1-cf8f-4dbf-ac08-5176940b10b7", "name": "VALPROMIDE", "unii": "RUA6CWU76G", "linking_id": "RUA6CWU76G", "ref_pname": "VALPROMIDE", "substance_class": "reference" } }, { "uuid": "e392cf3d-e88a-488a-a859-dc2dce1a9d8f", "amount": { "uuid": "a35eb16d-b220-4168-aa55-3aac4ba3fcdb" }, "type": "PRODRUG->METABOLITE ACTIVE", "references": [ "a7a470d7-aecc-4aa7-85b8-a1612259eda0" ], "related_substance": { "uuid": "26fecf6d-09cb-42c1-a23c-e9b7090dcdb9", "refuuid": "da8ecae2-82b3-4e71-a415-b55ff2f42c05", "name": "VALPROATE PIVOXIL", "unii": "9F5A05A29T", "linking_id": "9F5A05A29T", "ref_pname": "VALPROATE PIVOXIL", "substance_class": "reference" } } ], "names": [ { "uuid": "57f67d2b-a4ac-4a24-8de5-29509baf07db", "name": "44089", "stdName": "44089", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "76b23f5f-c6fd-40e5-b064-d89360e4da5b" ], "display_name": false }, { "uuid": "26147d4c-4a1c-4dd7-a493-3c4a4ff477e6", "name": "DEPAKENE", "stdName": "DEPAKENE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "76b23f5f-c6fd-40e5-b064-d89360e4da5b" ], "display_name": false }, { "uuid": "2e8c40da-96bb-4709-b446-df67d7522b31", "name": "PENTANOIC ACID, 2-PROPYL", "stdName": "PENTANOIC ACID, 2-PROPYL", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5711a9f7-7f27-4f86-86e7-735da8b3adca" ], "display_name": false }, { "uuid": "92767b18-6f53-47f8-96c1-bf96355ee5a9", "name": "Propylvaleric acid", "stdName": "PROPYLVALERIC ACID", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "5711a9f7-7f27-4f86-86e7-735da8b3adca" ], "display_name": false }, { "uuid": "6378ce94-fe71-4eda-a81f-da0eff7e98a4", "name": "VALPROATE", "stdName": "VALPROATE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "2c9fd511-09d7-4888-a6ce-fb438691678c" ], "display_name": false }, { "uuid": "fe519830-6d3b-4781-90fb-e36bc6d4490a", "name": "VALPROIC ACID", "stdName": "VALPROIC ACID", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "b933bf92-c20a-4c3b-b448-e61cd2a3a792", "8ecf842f-fec2-4daf-a7e9-72e91574f001", "41367c67-3b4c-4a1d-9569-0e762d2ea60b", "38ffd287-474e-41b9-855f-0d253c92851f", "02e030a5-41dc-4a32-a790-9e365335e5bf", "65b18d95-05db-436a-bf06-aa4f5633c35b", "7f15821c-cd57-4645-8270-138f8feff4c5", "0aec45fe-baea-46a0-aea4-ec9f48d9cc5b", "c5776dc5-28d3-4018-9c69-9ac0345c705b", "3ef6a40d-9dac-41cc-ae2e-a398fab40edf", "e3715df7-8e0f-42af-9cca-39e8a80dc100", "06ec99e4-c005-4d2c-9f82-0c4e3904e9ed", "f52cec2a-34b2-4b4b-9347-4a00ab686c5b", "e7818c73-927f-4a7d-a925-a148d4662712", "e0b8ae7f-e0bc-46fc-a682-dd852d3fe276", "6246236a-d96b-4d6b-9953-20299c0c7f86", "ac668a2d-92af-43dc-acdd-60bb4cf16785", "0fcbcfb1-a767-4825-922d-7c45f40fff81", "893a2397-116f-41ca-8da2-7ee418b4110f", "ae7b039f-3919-4944-82fd-4dd3d1c1ebb1", "85a12989-d582-4371-b06a-3caa18ce3ff8", "65fea249-8cae-4f26-a1da-b7f7c0fa9c09", "9314eb8d-bc9b-4847-8f24-96873b74bd9f" ], "display_name": true, "domains": [ "drug", "cosmetic" ], "name_orgs": [ { "uuid": "39a7d269-d6d9-4629-8818-b8ef457d38ce", "name_org": "INN" }, { "uuid": "25641b74-34ab-4914-b473-44a514d2a0fb", "name_org": "USAN" }, { "uuid": "c7f1aa81-7c3c-49cc-a49c-881a8507e494", "name_org": "INCI" } ] }, { "uuid": "a996e808-d561-4633-bb69-f17c4b05ae3a", "name": "VALPROIC ACID EXTENDED RELEASE", "stdName": "VALPROIC ACID EXTENDED RELEASE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "bf1375cf-e56f-4067-8f75-769561b95580" ], "display_name": false }, { "uuid": "0c924933-fe24-4f83-9bc2-2e587ad45920", "name": "VALPROIC ACID [EP IMPURITY]", "stdName": "VALPROIC ACID [EP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "06ec99e4-c005-4d2c-9f82-0c4e3904e9ed" ], "display_name": false }, { "uuid": "e4df2486-9d27-28ef-175b-92daeb203c8e", "name": "VALPROIC ACID [EP MONOGRAPH]", "stdName": "VALPROIC ACID [EP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d18b71a4-6f73-78fc-8a69-cc7939c289e2" ], "display_name": false }, { "uuid": "828c1053-72c7-4ea9-a97e-d688f2f5826c", "name": "VALPROIC ACID [HSDB]", "stdName": "VALPROIC ACID [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "6246236a-d96b-4d6b-9953-20299c0c7f86" ], "display_name": false }, { "uuid": "ebd7cc0e-f677-4d99-9f86-089a19cbcd6e", "name": "VALPROIC ACID [MART.]", "stdName": "VALPROIC ACID [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b933bf92-c20a-4c3b-b448-e61cd2a3a792" ], "display_name": false }, { "uuid": "0434dacf-1af3-4d68-8c84-24d1a9a31d03", "name": "VALPROIC ACID [MI]", "stdName": "VALPROIC ACID [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c5776dc5-28d3-4018-9c69-9ac0345c705b" ], "display_name": false }, { "uuid": "805a2923-875a-4fca-a724-4448ae67836a", "name": "VALPROIC ACID [ORANGE BOOK]", "stdName": "VALPROIC ACID [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "ac668a2d-92af-43dc-acdd-60bb4cf16785" ], "display_name": false }, { "uuid": "fa262f99-1a27-485a-896c-244e78ec1d50", "name": "VALPROIC ACID [USAN]", "stdName": "VALPROIC ACID [USAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "e7818c73-927f-4a7d-a925-a148d4662712" ], "display_name": false }, { "uuid": "f1371c14-1dba-0b2f-4ca7-80d160e97e7a", "name": "VALPROIC ACID [USP IMPURITY]", "stdName": "VALPROIC ACID [USP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "ae7b039f-3919-4944-82fd-4dd3d1c1ebb1" ], "display_name": false }, { "uuid": "c48c6db6-1c4d-291a-1562-2f43fb033b0a", "name": "VALPROIC ACID [USP MONOGRAPH]", "stdName": "VALPROIC ACID [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "b70fed07-6d05-6e46-7eaa-2092ce61b4a1" ], "display_name": false }, { "uuid": "5bdf4274-00a2-4489-9b3e-77c88252c4de", "name": "VALPROIC ACID [USP-RS]", "stdName": "VALPROIC ACID [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "893a2397-116f-41ca-8da2-7ee418b4110f" ], "display_name": false }, { "uuid": "09fb7a42-de48-4cae-9360-a0be264c82e6", "name": "VALPROIC ACID [VANDF]", "stdName": "VALPROIC ACID [VANDF]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f52cec2a-34b2-4b4b-9347-4a00ab686c5b" ], "display_name": false }, { "uuid": "8ec78eb1-340a-2dc8-809d-9f39cbc4db5f", "name": "Valproic acid [WHO-DD]", "stdName": "VALPROIC ACID [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5174d165-3bc7-e2de-2cf6-51ba7e4c6685" ], "display_name": false }, { "uuid": "dc2e45b1-b518-4ef6-ab4d-2670b9b805d7", "name": "valproic acid [INN]", "stdName": "VALPROIC ACID [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "65b18d95-05db-436a-bf06-aa4f5633c35b" ], "display_name": false } ], "modifications": { "uuid": "7066101e-33e8-4bd1-822f-6899492432e9" } } ] }